Publication — IRIC

MMP-9 expression varies according to molecular subtypes of breast cancer.

In 2014, breast cancer remains a major cause of mortality worldwide mostly due to tumor relapse and metastasis. There is currently a great interest in identifying cancer biomarkers and signalling pathways mechanistically related to breast cancer progression. Matrix metalloproteinase-9 (MMP-9) is a member of matrix degrading enzymes involved in cancer development, invasion and metastasis. Our objective was to investigate MMP-9 expression in normal human breast tissue and to compare it to that of breast cancer of various histological grades and molecular subtypes. We also sought to correlate MMP-9 expression with the incidence of metastasis, survival rates and relapse in breast cancer patients.

Date de publication
23 août 2014
Chercheurs
Yousef EM, Tahir MR, St-Pierre Y, Gaboury L
Référence PubMed
BMC Cancer 2014;14:609
ID PubMed
25151367
Affiliation
Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Canada. louis.gaboury@umontreal.ca.